The Apolipoprotein E ε4 Allele and Outcome in Cerebrovascular Disease

Stroke - Tập 29 Số 9 - Trang 1882-1887 - 1998
Mark O. McCarron1,2, Keith W. Muir1,3, Christopher J. Weir4,1, Alexander Dyker5,1, I Bone1,6, James A. R. Nicoll1,7, Kennedy R. Lees1,8
1From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology (K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital; and Acute Stroke Unit, Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary (C.J.W., A.G.D., K.R.L.), Glasgow, Scotland.
2M. O. McCarron From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology (K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital
3K. W. Muir From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology (K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital
4C. J. Weir From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology (K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital
5A. G. Dyker From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology (K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital
6I. Bone From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology (K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital
7J.A.R. Nicoll From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology (K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital
8K.R. Lees From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology (K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital

Tóm tắt

Background and Purpose —Polymorphism of the apolipoprotein E gene ( APOE ) may influence outcome after traumatic brain injury and intracerebral hemorrhage, with the ε4 allele being associated with poorer prognosis. We investigated APOE allele distribution in acute stroke and the effect of the ε4 allele on outcome. Methods — APOE genotypes were determined in 714 stroke patients: 640 ischemic stroke and 74 intracerebral hemorrhage patients. The survival effect of the ε4 allele was assessed with the use of a stratified log-rank test. A Cox proportional hazards regression model was used to estimate the independent effect of ε4 dose (0, 1, or 2) on survival, and logistic regression was used to determine the effect on 3-month outcome (good if alive at home, poor if in care or dead). Results —Allele distribution matched the general population with no difference between the ischemic and hemorrhagic groups. Survival in the entire cohort was unaffected by ε4 dose. Improved survival with increasing ε4 dose was found in the ischemic group (relative hazard=0.76 per allele; P =0.04). If transient ischemic attacks were excluded, a trend for improved survival persisted ( P =0.06). With intracerebral hemorrhage, a trend was seen toward reduced survival with ε4 ( P =0.07, log-rank test). Three-month outcome in the ischemic group was unaffected by ε4 dose, and a trend toward poorer outcome with ε4 was seen for intracerebral hemorrhage ( P =0.10). Conclusions —The APOE ε4 allele had divergent effects on survival and outcome in ischemic and hemorrhagic strokes in this population. The reported adverse effect on patients with intracerebral hemorrhage was supported. The favorable survival effect on ischemic stroke patients requires further study.

Từ khóa


Tài liệu tham khảo

10.1016/0166-2236(94)90156-2

10.1073/pnas.90.5.1977

10.1161/01.ATV.8.1.1

10.1161/circ.91.2.265

10.1161/str.24.5.8488520

10.1161/str.23.11.1440702

10.1161/atvb.17.11.2880

Mahieux F Bailleul S Fenelon G Couderc R Laruelle P Guillard A. Prevalence of apolipoprotein E phenotypes in patients with acute ischemic stroke. Stroke. 1990;21(suppl I):I-115.

Coria F, Rubio I, Nunez E, Santa Engracia N, Bayon C, Cuadrado N. Apolipoprotein E variants in ischemic stroke. Stroke. 1995;26:2375–2376. Letter.

10.1161/str.27.8.1310

10.1001/archneur.1996.00550040031011

10.1161/atvb.15.9.1280

10.1161/str.28.12.2410

10.1002/ana.410380219

10.1002/ana.410410607

Kalaria RN, Premkumar DRD. Apolipoprotein E genotype and cerebral amyloid angiopathy. Lancet. 1995;346:1424. Letter.

10.1002/ana.410410604

10.1016/S0304-3940(98)00286-9

10.1016/S0140-6736(97)04318-3

10.1001/jama.1997.03550020068040

10.1038/nm0995-852

10.1016/S0140-6736(95)91411-0

10.1016/0140-6736(91)93206-O

Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;41:479–486.

Kendrick S, Clarke J. The Scottish record linkage system. Health Bull (Edinb). 1993;51:1–15.

10.1097/00004872-198604000-00003

10.1016/0895-4356(95)00530-7

10.1136/bmj.314.7094.1584

10.1136/bmj.314.7090.1303

10.1056/NEJM199512143332401

10.1056/NEJM199512143332402

Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187–220.

10.1111/j.1399-0004.1984.tb01995.x

10.1161/str.27.8.1333

10.1056/NEJM199607183350308

10.1161/str.18.2.3551211

10.1161/str.27.10.1817

10.1111/j.1365-2990.1996.tb01113.x

10.1016/S0006-8993(97)00411-3

10.1097/00004647-199707000-00005

10.1006/exnr.1995.1088

10.1126/science.8171342

Puttfarcken PS, Manelli AM, Falduto MT, Getz GS, LaDu MJ. Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures. J Neurochem. 1997;68:760–769.

10.1038/ng0996-55

10.1038/380168a0

10.1016/S0165-5728(97)00021-0

10.1016/0021-9150(94)90011-6

Thông tin
Thông tin xuất bản

Stroke

Tập 29 Số 9

1882-1887

Thông tin tác giả